Tarsus Pharmaceuticals (TARS) Asset Utilization Ratio (2021 - 2026)

Tarsus Pharmaceuticals' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.94 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio rose 75.8% year-over-year to 0.94 in Q1 2026; TTM through Mar 2026 was 0.94, a 75.8% increase from a year earlier, with the FY2025 full-year figure at 0.96, up 68.78% from the prior year.
• Asset Utilization Ratio rose to 0.94 in Q1 2026 per TARS's latest filing, from 0.82 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.94 in Q1 2026 and bottomed at 0.06 in Q2 2023.
• The 5-year median for Asset Utilization Ratio is 0.14 (2024), against an average of 0.32.
• Across the five-year window, Asset Utilization Ratio sank 77.06% in 2022 and jumped 643.11% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.11 in 2022, then sank by 41.22% to 0.07 in 2023, then soared by 643.11% to 0.49 in 2024, then soared by 69.45% to 0.82 in 2025, then increased by 13.72% to 0.94 in 2026.
• Per Business Quant, the three latest TARS Asset Utilization Ratio figures stand at 0.94 (Q1 2026), 0.82 (Q4 2025), and 0.71 (Q3 2025).